Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$223.05 - $302.68 $332,790 - $451,598
1,492 New
1,492 $425,000
Q1 2022

May 16, 2022

SELL
$127.96 - $207.36 $619,966 - $1 Million
-4,845 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$165.13 - $241.83 $23,283 - $34,098
141 Added 3.0%
4,845 $864,000
Q3 2021

Nov 15, 2021

SELL
$163.99 - $235.57 $56,904 - $81,742
-347 Reduced 6.87%
4,704 $968,000
Q2 2021

Aug 16, 2021

BUY
$131.45 - $201.49 $281,960 - $432,196
2,145 Added 73.81%
5,051 $958,000
Q1 2021

May 17, 2021

BUY
$92.73 - $142.05 $269,473 - $412,797
2,906 New
2,906 $379,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.